bioRxiv · 10.1101/2021.02.17.431446
Nuclear HMGB1 protects from non-alcoholic fatty liver diseases through negative regulation of liver X receptor
Abstract
Dysregulations of lipid metabolism in the liver may trigger steatosis progression leading to potentially severe clinical consequences such as non-alcoholic fatty liver diseases (NAFLD). Molecular mechanisms underlying liver lipogenesis are very complex and fine-tuned by chromatin dynamics and the activity of multiple key transcription factors. Here, we demonstrate that the nuclear factor HMGB1 acts as a strong repressor of liver lipogenesis during metabolic stress in NAFLD. Mice with liver-specific Hmgb1-deficiency display exacerbated liver steatosis and hepatic insulin resistance when subjected to a high-fat diet or after fasting/refeeding. Global transcriptome and functional analysis revealed that the deletion of Hmgb1 gene enhances LXR activity resulting in increased lipogenesis. HMGB1 repression is not mediated through nucleosome landscape re-organization but rather via a preferential DNA occupation in region carrying genes regulated by LXR. Together these findings suggest that hepatocellular HMGB1 protects from liver steatosis development. HMGB1 may constitute a new attractive option to therapeutically target LXR axis during NAFLD.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Personnaz, J., Piccolo, E., Dortignac, A., Iacovoni, J. S., Mariette, J., Polizzi, A., Batut, A., Deleruyelle, S., Paccoud, R., Moreau, E., Martins, F., Clouaire, T., Benhamed, F., Montagner, A., Wahli, W. A., Schwabe, R. F., Yart, A., Castan-Laurell, I., Postic, C., Moro, C., Legube, G., Lee, C.-H., Guillou, H., Valet, P., Dray, C., Pradere, J.-P.. 2021-02-17. Nuclear HMGB1 protects from non-alcoholic fatty liver diseases through negative regulation of liver X receptor. https://doi.org/10.1101/2021.02.17.431446
Cite the original work for its findings. Save a collection to share your selection of sources.